Its all about perceptions and viewpoints.
Back in January/February 2015 our market cap was circa $300-$400M after the Abbvie announcement which only gave us a $5 million cash injection. At the time of the announcement we had $10 million cash in the bank, enough to keep the company going for 2-3 months.
Fast forward to now, we have Amgen and a capital injection, we are likely to get a CEO that has appropriate qualifications, discipline and experience. We have to be closer to production and revenue than we were back in Jan/Feb 2015. Yet our market cap is $47 million.
Is this a case of the share price over-shooting one way, and then to the other...
- Forums
- ASX - By Stock
- UNS
- Time for a deep breath
Time for a deep breath, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online